Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States? (original) (raw)

• Bhutani VK, Johnson LH, Jeffrey Maisels M, Newman TB, Phibbs C, Stark AR et al. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol 2004; 24: 650–662.
  Article Google Scholar
• Johnson L, Bhutani VK, Karp K, Sivieri M, Shapiro SM . Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). J Perinatol 2009; 29 (S1): S25–S45.
  Article Google Scholar
• Beutler E . Glucose-6-phosphate dehydrogenase deficiency. New Eng J Med 1991; 324: 169–174.
  Article CAS Google Scholar
• Beutler E . G6PD deficiency. Blood 1994; 84: 3613–3636.
  CAS Google Scholar
• Valaes T, Karaklis A, Stravrakakis D, Bavela-Stravrakakis K, Perakis A, Doxiadis SA . Incidence and mechanism of neonatal jaundice related to glucose-6-phosphate dehydrogenase deficiency. Pediatr Res 1969; 3: 448–458.
  Article CAS Google Scholar
• Online Mendelian Inheritance in Man [OMIM]: glucose-6-phosphate dehydrogenase; G6PD http://omim.org/entry/305900 Accessed on 10 August 2011.
• Beutler E . G6PD. population genetics and clinical manifestations. Blood Rev 1996; 10: 45–52.
  Article CAS Google Scholar
• Cappellini MD, Fiorelli G . Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008; 371: 64–74.
  Article CAS Google Scholar
• Subcommittee on Hyperbilirubinemia, American Academy of Pediatrics. Clinical practice guideline: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297–316.
  Article Google Scholar
• Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF . Hyperbilirubinemia in the newborn infant ⩾35 weeks’ gestation: an update with clarifications. Pediatrics 2009; 124: 1193–1198.
  Article Google Scholar
• Lin Z, Fontaine JM, Freer DE, Naylor EW . Alternative DNA-based newborn screening for glucose-6-phosphate dehydrogenase deficiency. Mol Genet Metab 2005; 86: 212–219.
  Article CAS Google Scholar
• Nock ML, Johnson EM, Krugman RR, Di Fiore JM, Fitzgerald S, Sandhaus LM et al. Implementation and analysis of a pilot in-hospital newborn screening program for glucose-6-phosphate dehydrogenase deficiency in the United States. J Perinatol 2011; 31: 112–117.
  Article CAS Google Scholar
• Brown AK, Damus K, Kim MH, King K, Harper R, Campbell D et al. Factors relating to readmission of term and near term neonates in the first two weeks of life. J Perinat Med 1999; 27: 263–275.
  Article CAS Google Scholar
• Newman TB, Liljestrand P, Escobar GJ . Combining clinical risk factors with serum bilirubin levels to predict hyperbilirubinemia in newborns. Arch Pediatr Adolesc Med 2005; 159: 113–119.
  Article Google Scholar
• Keren R, Bhutani VK, Luan X, Nihtianova S, Cnaan A, Schwartz JS . Identifying newborns at risk of significant hyperbilirubinemia.’. Arch Dis Child 2005; 90: 415–421.
  Article CAS Google Scholar
• Johnson L, Bhutani VK, Brown AK . ‘System-based approach to management of neonatal jaundice and prevention of kernicterus.’. J Pediatr 2002; 140: 396–403.
  Article Google Scholar
• Manning DJ, Maxwell MJ, Todd PJ, Platt MJ . Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the United Kingdom and Ireland. Arch Dis Child Fetal Neonatal Ed 2007; 92 (5): F342–F346.
  Article Google Scholar
• Sgro M, Campbell D, Shah V . Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ 2006; 175: 587–590.
  Article Google Scholar
• Al Otaibi SF, Blaser S, MacGregor DL . ‘Neurological Complications of Kernicterus.’. Canadian J Neurol Sci 2005; 32: 311–315.
  Article Google Scholar
• Sgro M, Campbell D, Barozzino T, Shah V . Acute neurological findings in a national cohort of neonates with severe neonatal hyperbilirubinemia. J Perinatol 2011; 31: 392–396.
  Article CAS Google Scholar
• Sgro M, Campbell DM, Kandasamy S, Shah V . Incidence of chronic bilirubin encephalopathy in Canada, 2007-2008. Pediatrics 2012; 130: e886–e890.
  Article Google Scholar
• Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E . The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis.’. Blood Cells Mol Dis 2009; 42: 267–278.
  Article CAS Google Scholar
• Chinevere TD, Murray CK, Grant E, Johnson GA, Duelm F, Hospenthal DR . ‘Prevalence of glucose‐6‐phosphate dehydrogenase deficiency in U.S. Army personnel.’. Mil Med 2006; 171: 905–907.
  Article Google Scholar
• Riskin A, Gery N, Kugelman A, Hemo M, Spevak I, Bader DJ . Glucose-6-phosphate dehydrogenase deficiency and borderline deficiency: association with neonatal hyperbilirubinemia. Pediatrics 2012; 161: 191–196.
  Article CAS Google Scholar
• Kaplan M, Herschel M, Hammerman C, Hoyer JD, Heller GZ, Stevenson DK . Neonatal hyperbilirubinemia in African American males: the importance of glucose-6-phosphate dehydrogenase deficiency. J of Pediatr 2006; 149: 83–88.
  Article CAS Google Scholar
• Fetus and Newborn Committee, Canadian Paediatric Society. Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks’ gestation) - summary. Paediatr Child Health 2007; 12: 401–418.
  Article Google Scholar
• Kaplan M, Hammerman C, Feldman R, Brisk R . Predischarge bilirubin screening in glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics 2000; 105: 533–537.
  Article CAS Google Scholar
• Bhutani VK . Jaundice due to glucose-6-phosphate dehydrogenase deficiency. Neoreviews 2012; 13: e166–e177.
  Article Google Scholar
• MacDonald MG . ‘Hidden risks: early discharge and bilirubin toxicity due to glucose 6-phosphate dehydrogenase deficiency.’. Pediatrics 1995; 96: 734–738.
  CAS Google Scholar
• Kaplan M, Beutler E, Vreman HJ, Hammerman C, Levy-Lahad E, Renbaum P et al. Neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient heterozygotes’. Pediatrics 1999; 104: 68–74.
  Article CAS Google Scholar
• Kaplan M, Hammerman C . Hemolytic disorders and their management in Stevenson DK, Maisels MJ, Watchko JF, (eds) Care of the Jaundiced Neonate. The McGraw-Hill Companies: New York, USA, 2012 pp 145–173.
  Google Scholar
• Kaplan M, Hammerman C . The need for neonatal glucose‐6‐phosphate dehydrogenase screening: a global perspective. J Perinatol 2009; 29 (Suppl 1): S46–S52.
  Article CAS Google Scholar
• Kaplan M, Hammerman C . Glucose-6-phosphate dehydrogenase deficiency: a hidden risk for kernicterus. Semin Perinatol 2004; 28: 356–364.
  Article Google Scholar
• Slusher TM, Vreman HJ, McLaren DW, Lewison LJ, Brown AK, Stevenson DK . Glucose-6-phosphate dehydrogenase deficiency and carboxyhemoglobin concentrations associated with bilirubin-related morbidity and death in Nigerian infants. J Pediatr 1995; 126: 102–108.
  Article CAS Google Scholar
• Kaplan M, Renbaum P, Levy‐Lahad E, Hammerman C, Lahad A, Beutler E . Gilbert syndrome and glucose‐6‐phosphate dehydrogenase deficiency: a dose‐dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci USA 1997; 94: 12128–12132.
  Article CAS Google Scholar
• Kaplan M, Herschel M, Hammerman C, Hoyer JD, Stevenson DK . Hyperbilirubinemia among african american, glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics 2004; 114: e213–e219.
  Article Google Scholar
• Kaplan M, Muraca M, Vreman HJ, Hammerman C, Vilei MT, Rubaltelli FF et al. Neonatal bilirubin production-conjugation imbalance: effect of glucose-6-phosphate dehydrogenase deficiency and borderline prematurity. Arch Dis Child Fetal Neonatal Ed 2005; 90: 123–127.
  Article Google Scholar
• Missiou-Tsagaraki S . Screening for glucose-6-phosphate dehydrogenase deficiency as a preventive measure: prevalence among 1,286,000 Greek newborn infants. J Pediatr 1991; 119: 293–299.
  Article CAS Google Scholar
• Hsaio KJ, Chiang S, Wu SJ, Wu KF . Experience of neonatal G6PD deficiency screening in Taiwan In: Wilcken B, Webster D, (eds) Neonatal screening in the nineties. Leura, The Kelvin Press: NSW, Australia, 1991 pp 217–218.
  Google Scholar
• Mallouh AA, Imseeh G, Abu-Osba YK, Hamdan JA . Screening for glucose-6-phosphate dehydrogenase deficiency can prevent severe neonatal jaundice. Ann Trop Paediatr 1992; 12: 391–395.
  Article CAS Google Scholar
• Meloni T, Forteleoni G, Meloni GF . Marked decline of favism after neonatal glucose-6-phosphate dehydrogenase screening and health education: the northern Sardinian experience. Acta Haematol 1992; 87: 29–31.
  Article CAS Google Scholar
• Lo KK, Chan ML, Lai SSL, Li KCK, Hung P, Lam STS et al. Neonatal screening for glucose-6-phosphate dehydrogenase deficiency in Hong Kong In Lam T, Pang C, (eds) Neonatal and Perinatal Screening: the Asian Pacific Perspectives. The Chinese University Press: Hong Kong, 1995 pp 33–35.
  Google Scholar
• Joseph R, Ho LY, Gomez JM, Rajdurai VS, Sivasankaran S, Yip YY . Mass newborn screening for glucose-6-phosphate dehydrogenase deficiency in Singapore. Southeast Asian J Trop Med Public Health 1999; 30 (Suppl 2): 70–71.
  Google Scholar
• Padilla CD . ‘Newborn screening in the Philippines.’. Southeast Asian J Trop Med Public Health 2003; 34 (Suppl 3): 87–88.
  PubMed Google Scholar
• Padilla CD, Therrell BL . Newborn screening in the Asia Pacific region. J Inherit Metab Dis 2007; 30: 490–506.
  Article Google Scholar
• Algur N, Avraham I, Hammerman C, Kaplan M . Quantitative neonatal glucose-6-phosphate dehydrogenase screening: distribution, reference values, and classification by phenotype. J Pediatr 2012; 161: 197–200.
  Article CAS Google Scholar
• Castro SM, Weber R, Dadalt V, Santos VF, Reclos GJ, Pass KA et al. Evaluation of glucose-6-phosphate dehydrogenase stability in blood samples under different collection and storage conditions. Clin Chem 2005; 51: 1080–1081.
  Article CAS Google Scholar
• Panepinto JA, Magid D, Rewers MJ, Lane PA . Universal versus targeted screening of infants for sickle cell disease: a cost-effectiveness analysis. J Pediatr 2000; 136: 201–208.
  Article CAS Google Scholar
• WHO Working Group. Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ 1989; 67: 601–611.
  Google Scholar
• Beutler E, Blume KG, Kaplan JC, Löhr GW, Ramot B, Valentine WN . International Committee for standardization in haematology: recommended screening test for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. Br J of Haematol 1979; 43: 465–467.
  Article CAS Google Scholar
• Beal AC, Chou SC, Palmer RH, Testa MA, Newman C et al. ‘The Changing Face of Race: Risk Factors for Neonatal Hyperbilirubinemia.’. Pediatrics 2006; 117: 1618–1625.
  Article Google Scholar
• Fairbanks VF, Fernandez MN . The Identification of Metabolic Errors Associated With Hemolytic Anemia. JAMA 1969; 208: 316–320.
  Article CAS Google Scholar
• Watchko JF . Hyperbilirubinemia in African American neonates: clinical issues and current challenges. Semin Fetal Neonatal Med 2010; 15: 176–182.
  Article Google Scholar
• Kaplan M, Beutler E, Vreman HJ, Hammerman C, Levy‐Lahad E, Renbaum P et al. Neonatal hyperbilirubinemia in glucose‐6‐ phosphate dehydrogenase‐deficient heterozygotes. Pediatrics 1999; 104: 68–74.
  Article CAS Google Scholar
• Bhutani VK, Sivieri EM, Johnson L . Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999; 103: 6–14.
  Article CAS Google Scholar
• Kappas A, Drummond GS, Valaes T . A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns. Pediatrics 2001; 108: 25–30.
  Article CAS Google Scholar